Form 4 KALOBIOS PHARMACEUTICALS For: Nov 24 Filed by: Shkreli Martin
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
KaloBios Pharma (KBIO) Could Drop 50% By Early Next Week: Tim Sykes
November 24, 2015 12:46 PM ESTTim Sykes thinks KaloBios Pharma (NASDAQ: KBIO) could drop 50% by early next week, according to the New York... More
KaloBios Pharma (KBIO) CEO Shkreli Bought 5,000 More Shares
November 24, 2015 11:23 AM ESTKaloBios Pharma (NASDAQ: KBIO) CEO Martin Shkreli bought more shares.
Shkreli purchased 5,000 shares on November 24 at $38.15 apiece, according to a Form 4 filed Tuesday.
... More